Medpace
MEDP
340 hedge funds and large institutions have $3.94B invested in Medpace in 2022 Q2 according to their latest regulatory filings, with 43 funds opening new positions, 112 increasing their positions, 141 reducing their positions, and 44 closing their positions.
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
2% less first-time investments, than exits
New positions opened: 43 | Existing positions closed: 44
6% less call options, than puts
Call options by funds: $16.4M | Put options by funds: $17.4M
3% less funds holding
Funds holding: 349 → 340 (-9)
3.09% less ownership
Funds ownership: 81.13% → 78.04% (-3.1%)
12% less capital invested
Capital invested by funds: $4.48B → $3.94B (-$536M)
21% less repeat investments, than reductions
Existing positions increased: 112 | Existing positions reduced: 141
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$34M |
| 2 |
CCM
Channing Capital Management
Chicago,
Illinois
|
+$23.1M |
| 3 |
GT
Glenmede Trust
Philadelphia,
Pennsylvania
|
+$16.5M |
| 4 |
RP
Riverbridge Partners
Minneapolis,
Minnesota
|
+$15M |
| 5 |
Goldman Sachs
New York
|
+$13.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$54.6M |
| 2 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$51.4M |
| 3 |
VVP
Vulcan Value Partners
Birmingham,
Alabama
|
-$21.1M |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$19.7M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$19M |
MEDP Hedge Fund Activity: Q2 2022 in Review
340 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Medpace (MEDP) for Q2 2022, worth a combined $3.94B — down 12% from $4.48B a quarter earlier.
Sellers outnumbered buyers: 44 funds closed out of MEDP and 43 opened new positions — a net loss of 1 holder — while 141 trimmed existing stakes and 112 added.
The largest buyer was ArrowMark Colorado Holdings, opening a new position worth an estimated $34M. The largest seller was BlackRock, cutting an estimated $54.6M.
- 340 institutional investors held Medpace (MEDP) as of Q2 2022, down from 349 in Q1 2022.
- Funds reported $3.94B of Medpace stock for Q2 2022, down 12% quarter-over-quarter.
- 43 funds opened new Medpace positions in Q2 2022 and 44 closed out, a net change of -1 holder.
- The largest Medpace buyer in Q2 2022 was ArrowMark Colorado Holdings, an estimated $34M added.
- The largest Medpace seller in Q2 2022 was BlackRock, an estimated $54.6M sold.
Based on aggregated 13F filings for Q2 2022.